MCC
NKTR icon

Money Concepts Capital’s Nektar Therapeutics NKTR Stock Holding History

Money Concepts Capital’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12
Closed -$401 – 2027
2022
Q4 		$401 Buy
12
+6
+100% +$290 ﹤0.01% 3031
2022
Q3 		$0 Hold
6
– – ﹤0.01% 1629
2022
Q2 		$0 Sell
6
-6
-50% -$379 ﹤0.01% 2201
2022
Q1 		$1K Buy
+12
New +$1.78K ﹤0.01% 2589

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Money Concepts Capital's NKTR Position: Q1 2023 in Review

Money Concepts Capital sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 12 shares — an estimated $401 sold.

Money Concepts Capital first reported a position in NKTR in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

  • Money Concepts Capital reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 12 Nektar Therapeutics shares in Q1 2023, an estimated $401.
  • Money Concepts Capital first reported a position in Nektar Therapeutics in Q1 2022 and held it in 4 quarters.
  • Money Concepts Capital's Nektar Therapeutics position peaked at $1K in Q1 2022.
  • 194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.